Literature DB >> 23413420

Influenza vaccine effectiveness in the community and the household.

Suzanne E Ohmit1, Joshua G Petrie, Ryan E Malosh, Benjamin J Cowling, Mark G Thompson, David K Shay, Arnold S Monto.   

Abstract

BACKGROUND: There is a recognized need to determine influenza vaccine effectiveness on an annual basis and a long history of studying respiratory illnesses in households.
METHODS: We recruited 328 households with 1441 members, including 839 children, and followed them during the 2010-2011 influenza season. Specimens were collected from subjects with reported acute respiratory illnesses and tested by real-time reverse transcriptase polymerase chain reaction. Receipt of influenza vaccine was defined based on documented evidence of vaccination in medical records or an immunization registry. The effectiveness of 2010-2011 influenza vaccination in preventing laboratory-confirmed influenza was estimated using Cox proportional hazards models adjusted for age and presence of high-risk condition, and stratified by prior season (2009-2010) vaccination status.
RESULTS: Influenza was identified in 78 (24%) households and 125 (9%) individuals; the infection risk was 8.5% in the vaccinated and 8.9% in the unvaccinated (P = .83). Adjusted vaccine effectiveness in preventing community-acquired influenza was 31% (95% confidence interval [CI], -7% to 55%). In vaccinated subjects with no evidence of prior season vaccination, significant protection (62% [95% CI, 17%-82%]) against community-acquired influenza was demonstrated. Substantially lower effectiveness was noted among subjects who were vaccinated in both the current and prior season. There was no evidence that vaccination prevented household transmission once influenza was introduced; adults were at particular risk despite vaccination.
CONCLUSIONS: Vaccine effectiveness estimates were lower than those demonstrated in other observational studies carried out during the same season. The unexpected findings of lower effectiveness with repeated vaccination and no protection given household exposure require further study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23413420      PMCID: PMC3693492          DOI: 10.1093/cid/cit060

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Containing pandemic influenza at the source.

Authors:  Ira M Longini; Azhar Nizam; Shufu Xu; Kumnuan Ungchusak; Wanna Hanshaoworakul; Derek A T Cummings; M Elizabeth Halloran
Journal:  Science       Date:  2005-08-03       Impact factor: 47.728

2.  Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies.

Authors:  W E Beyer; I A de Bruijn; A M Palache; R G Westendorp; A D Osterhaus
Journal:  Arch Intern Med       Date:  1999-01-25

3.  Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.

Authors:  W E Beyer; A M Palache; M J Sprenger; E Hendriksen; J J Tukker; R Darioli; G L van der Water; N Masurel; A D Osterhaus
Journal:  Vaccine       Date:  1996-10       Impact factor: 3.641

4.  Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.

Authors:  W A Keitel; T R Cate; R B Couch; L L Huggins; K R Hess
Journal:  Vaccine       Date:  1997-07       Impact factor: 3.641

5.  Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial.

Authors:  Benjamin J Cowling; Sophia Ng; Edward S K Ma; Vicky J Fang; Hau Chi So; Winnie Wai; Calvin K Y Cheng; Jessica Y Wong; Kwok-Hung Chan; Dennis K M Ip; Susan S Chiu; J S Malik Peiris; Gabriel M Leung
Journal:  Clin Infect Dis       Date:  2012-06-05       Impact factor: 9.079

6.  Mitigation strategies for pandemic influenza in the United States.

Authors:  Timothy C Germann; Kai Kadau; Ira M Longini; Catherine A Macken
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

7.  Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains.

Authors:  John J Treanor; H Keipp Talbot; Suzanne E Ohmit; Laura A Coleman; Mark G Thompson; Po-Yung Cheng; Joshua G Petrie; Geraldine Lofthus; Jennifer K Meece; John V Williams; Lashondra Berman; Caroline Breese Hall; Arnold S Monto; Marie R Griffin; Edward Belongia; David K Shay
Journal:  Clin Infect Dis       Date:  2012-07-25       Impact factor: 9.079

Review 8.  Studies of the community and family: acute respiratory illness and infection.

Authors:  A S Monto
Journal:  Epidemiol Rev       Date:  1994       Impact factor: 6.222

9.  Strategies for mitigating an influenza pandemic.

Authors:  Neil M Ferguson; Derek A T Cummings; Christophe Fraser; James C Cajka; Philip C Cooley; Donald S Burke
Journal:  Nature       Date:  2006-04-26       Impact factor: 49.962

10.  Influence of prior influenza vaccination on antibody and B-cell responses.

Authors:  Sanae Sasaki; Xiao-Song He; Tyson H Holmes; Cornelia L Dekker; George W Kemble; Ann M Arvin; Harry B Greenberg
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

View more
  96 in total

1.  Influenza Vaccine Effectiveness in a Low-Income, Urban Community Cohort.

Authors:  Marie Smithgall; Celibell Y Vargas; Carrie Reed; Lyn Finelli; Philip LaRussa; Elaine L Larson; Lisa Saiman; Melissa S Stockwell
Journal:  Clin Infect Dis       Date:  2015-09-28       Impact factor: 9.079

2.  Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness.

Authors:  Saad B Omer; Varun K Phadke; Robert A Bednarczyk; Allison T Chamberlain; Jennifer L Brosseau; Walter A Orenstein
Journal:  J Infect Dis       Date:  2015-10-28       Impact factor: 5.226

Review 3.  A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children.

Authors:  Herve Caspard; Terho Heikkinen; Robert B Belshe; Christopher S Ambrose
Journal:  Hum Vaccin Immunother       Date:  2016-07-02       Impact factor: 3.452

4.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

Authors:  Suzanne E Ohmit; Mark G Thompson; Joshua G Petrie; Swathi N Thaker; Michael L Jackson; Edward A Belongia; Richard K Zimmerman; Manjusha Gaglani; Lois Lamerato; Sarah M Spencer; Lisa Jackson; Jennifer K Meece; Mary Patricia Nowalk; Juhee Song; Marcus Zervos; Po-Yung Cheng; Charles R Rinaldo; Lydia Clipper; David K Shay; Pedro Piedra; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

5.  Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.

Authors:  Kate Russell; Jessie R Chung; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Kempapura Murthy; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Brendan Flannery
Journal:  Vaccine       Date:  2018-02-28       Impact factor: 3.641

6.  Prevention of Influenza Hospitalization Among Adults in the United States, 2015-2016: Results From the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).

Authors:  Jill M Ferdinands; Manjusha Gaglani; Emily T Martin; Don Middleton; Arnold S Monto; Kempapura Murthy; Fernanda P Silveira; H Keipp Talbot; Richard Zimmerman; Elif Alyanak; Courtney Strickland; Sarah Spencer; Alicia M Fry
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

7.  Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.

Authors:  Suzanne E Ohmit; Joshua G Petrie; Ryan E Malosh; Alicia M Fry; Mark G Thompson; Arnold S Monto
Journal:  J Infect Dis       Date:  2014-11-21       Impact factor: 5.226

8.  Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.

Authors:  Peter H Goff; Tomoko Hayashi; Wenqian He; Shiyin Yao; Howard B Cottam; Gene S Tan; Brian Crain; Florian Krammer; Karen Messer; Minya Pu; Dennis A Carson; Peter Palese; Maripat Corr
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 9.  Influenza vaccines: challenges and solutions.

Authors:  Katherine Houser; Kanta Subbarao
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

10.  Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses.

Authors:  Mark G Thompson; Jessie Clippard; Joshua G Petrie; Michael L Jackson; Huong Q McLean; Manjusha Gaglani; Evelyn C Reis; Brendan Flannery; Arnold S Monto; Lisa Jackson; Edward A Belongia; Kempapura Murthy; Richard K Zimmerman; Swathi Thaker; Alicia M Fry
Journal:  Pediatr Infect Dis J       Date:  2016-03       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.